Thank you very much for the observation and the question.
I would answer by saying this: In the run-up to President Biden's visit to Canada, we saw other parliamentary committees—I don't think it was this one—singling out large American technology firms and large foreign innovative pharmaceutical firms for various levels of scrutiny and various questions. That creates a question in the minds of a lot of companies about how open Canada really is to foreign investment and companies that employ a lot of Canadians and bring technology and innovation into Canada, and how they would be treated.
When we think about AI.... There is so much emerging that it is much better for the U.S. and Canada to figure out how to work together vis-à-vis challenges around the world—whether they are in artificial intelligence, cyber or anything else—rather than trying to figure out how to have some kind of tit-for-tat experience targeting successful American firms.